Injectable peptide vialPeptide Observatory
RESEARCH PREVIEW
Evidence before claims.

No seller rankings.
No certified “safe” batches.

MEET KIRBY, FIONA & MEL

Who we are

Kirby, Fiona and Mel · Corporate leadership, community service and shared experience.

Kirby de Lanerolle

Kirby de Lanerolle

Co-founder & CEO · Conscience IQ

Kirby leads Conscience IQ, bringing together his work in human performance, psychology and neuroscience. Alongside Fiona, he oversees churches through WOWLife and the Apostolic Diocese of Ceylon. His experience spans organizational leadership, community development and public service.

Academic background
MSc, Psychology & Neuroscience — King’s College London.

Background: WOWLife ↗
Fiona de Lanerolle competing in a triathlon

Fiona de Lanerolle

Co-founder · Conscience IQ

Fiona brings a background in law, organizational development and human performance to Conscience IQ. She co-founded the Warehouse Project and, alongside Kirby, oversees churches through WOWLife. Her experience includes business, creative direction, community development and endurance sport.

Academic background
LLB (Hons) — University of Buckingham.
Master’s in Theology — Fuller Theological Seminary.
Certified High Flow Coach.

Photo & background: WOWLife ↗
Melissa (Mel) Wijegooneratne

Melissa “Mel” Wijegooneratne

Board Director · The Warehouse Project

Mel serves as International Administrative Director of WOW LIFE WORLD and a Board Director of the Warehouse Project. Her experience spans operations, project delivery and community development, including youth education and social empowerment.

Academic background
BSc, Anthropology and Politics — Oxford Brookes University.
Master’s in Global Cultures — King’s College London.

Photo & background: The Warehouse Project ↗

Why we are here

Our wider work spans Conscience IQ, Rapha Ltd and community leadership. Here, we contribute as fellow users and supporters of access to information.

We are peptide users and supporters of better information. We started Peptide Observatory for the sake of others: to make reports, experiences and evidence easier to find and understand.

As users ourselves, we are concerned about how unsafe parts of this industry have become. Unclear product quality, incomplete information and accounts of harm leave people trying to make decisions without a clear picture. We want to be there for those people, helping them see what has been reported and what remains uncertain.

We contribute from our own backgrounds and experience as users. Our support for informed research is not a claim that every peptide or product is safe. Personal experience does not establish clinical safety, and the Observatory does not replace individual medical advice.

KEEPING THE OBSERVATORY RUNNING

A small fee for a shared resource.

The USD 2.99 monthly membership fee is intended to cover retrieving information and the costs of hosting, maintenance and keeping the site running. Our purpose is to help others access information about reported benefits, harms and uncertainties.

Membership payments are not open yet. You can register your interest without being charged.

USD 2.99per month
THE SAFETY OBSERVATORY

We want you to be safe
while using peptides.

This site collects anecdotal reports from social media alongside research to help you understand reported benefits, harms and uncertainty. Updates every week from social media anecdotes.

Source review
12 September 2026
ANECDOTAL REPORTS

Reported incidents by month and peptide

These charts count selected adverse-event reports, not every collected post or comment. Publication dates are not necessarily incident dates.

Unverified anecdotes

13 selected adverse-event reports = 2 dated 2026 + 4 from earlier years + 7 with unresolved dates. All are included in the default peptide chart; only dated 2026 records can be placed on the monthly chart.

2Dated 2026 reports
Feb & MayMost reports: 1 per month · tied
7Unresolved dates · included below

2026 reports by publication month · 2 reports

0 = no dated report in this collection, not no incidents. The current month is partial; future months are outside the collection period.

2026 incident reports by platform

2 reports · the same dated reports as the monthly chart

Reddit · 2

Each report is counted once by platform. General discussion, questions and promotional posts in the collected-post totals are not counted as incidents.

Reports per peptide

All dates, including unresolved dates · 13 source records

Y-axis · Anecdotal incident reports

X-axis · Peptides

Most named: MOTS-C (5 each). A combination report counts once in the monthly total and once for each named peptide. This does not identify which compound caused the event or rank danger.

Verification status · all reports

13 source records · independent clinical verification

No independent clinical verification documented · 13

Independently clinically verified · 0

The collection currently contains no documented independent clinical verification. Reading a source, reviewing a submission or automatically screening text does not confirm diagnosis or causation. All reports are included in the peptide chart when no month is selected.

Date coverage · all reports

Every source record appears once here, including reports that cannot be assigned to a month.

Dated 2026 · 2

Earlier years · 4

Date unresolved · 7

Inspect dates, symptoms and original sources (13)
30 Dec 2023 · MOTS-C ↗

Itchy palms, diarrhoea, shakiness and increased heart rate; breathing difficulty explicitly denied. Author reported resolution within an hour.

PO-S001 · Reddit · Event date: “Today” in post; timezone not established
16 Feb 2026 · MOTS-C + SS-31 ↗

Hives, itching and throat tightening after combined exposure. Emergency-room attendance reported.

PO-S002 · Reddit · Event date: “Today” in post; timezone not established
22 May 2026 · Retatrutide ↗

Author reports anaphylaxis and posts an image described as a tryptase result. Emergency-room visit reported.

PO-S003 · Reddit · Event date: Before this follow-up post; exact event date unknown
20 Nov 2024 · CJC-1295 + Ipamorelin ↗

Breathing difficulty, tongue swelling, welts and rapid heart rate. Emergency treatment including epinephrine and oxygen reported.

PO-S004 · Reddit · Event date: “Last night” in post; local calendar date unknown
6 Jun 2017 · Sermorelin ↗

Persistent injection-site itching progressed to itchy palms and burning with later injections. Stopped treatment; reported little perceived benefit.

PO-S007 · ExcelMale · Event date: Symptoms described over preceding months
28 May 2019 · Ipamorelin ↗

Pounding heart, flushing, welts and itching after months of use. Reported symptoms subsided after about 20 minutes.

PO-S008 · ExcelMale · Event date: “Last night” in comment; exact local date not established
23–24 Jul 2026 · date conflict · MOTS-C + KLOW ↗

Author reports severe tongue/throat swelling and breathing difficulty after combined exposure. Ambulance care and four epinephrine injections reported.

PO-S009 · Instagram · Event date: Before upload; exact date not established
Publication date unverified · Tesamorelin + CJC-1295 ↗

Author reports hives, low blood pressure, fainting, sweating and increased pulse. About 45 minutes of symptoms reported; no emergency treatment stated.

PO-S013 · Facebook · Event date: “Last night” in post; exact date unknown

Anecdotal, selected public posts and comments; clinical diagnosis and causality unverified. These are report counts, not incidence rates or unique patient counts. Publication month may differ from event month. Reports with missing or conflicting dates are included in the all-dates peptide chart and source register, but excluded from the monthly chart. Counts across peptides can exceed the source-record total because a report may name more than one peptide.

Built around traceable evidence. 13 public posts and comments are indexed alongside FDA sources. See Sources & coverage for automated collection status.

Peptides indexed 13Initial evidence directory
Public-source accounts 136 posts + 7 comments · unverified
Certificate records 04Issuer authentication incomplete
Batch safety certification Not availableAbsence of reports ≠ safety
PUBLIC POSTS & COMMENTS

First-hand safety signals

13 source records

Initial collection plus reviewed and automatically screened imports

Reddit
6
Instagram
4
TikTok
0
YouTube
0
ExcelMale
2
Facebook
1

7 comments + 6 original posts. Selected for adverse-event content; not a representative sample, incidence rate or confirmed case count.

Initial collection access limits are documented under Sources & coverage.

PRIORITY SAFETY SIGNALS

Some questions
cannot wait.

Anaphylaxis, collapse and serious biological hazards need clinical assessment, not a forum consensus.

If someone has trouble breathing or collapses, contact local emergency services immediately. Do not wait for a report review.

Peptide evidence directory

What the sources say. What remains unknown.

13 of 13 molecules
PeptideEvidence signalPrimary concernPublic accountsFDA reports¹
Regulatory safety signalDosing errors · gastrointestinal events990
Regulatory safety signalDose escalation · product authenticity>730
Safety evidence limitedImmune response · purity uncertainty—
Regulatory safety signalIncreased heart rate · vasodilation—
Safety evidence limitedImmune response · uncertain causality—
Unapproved product concernUnapproved online products—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
Anecdotal · unverifiedPublic self-report · causality unresolved—
¹ FDA reports for compounded products, as of 31 May 2026. Not incidence, confirmed causality or a comparison of risk. — = unavailable.
PUBLIC POSTS & COMMENTS

Collection & review statistics

Some posts and comments are found and collected automatically by a bot for convenience. Automated collection does not verify the author, product, reported experience or claim.

Loading collection…

PURPOSE & TRANSPARENCY

Peptide controversies, with the uncertainty visible.

Our aim is to bring together posts about peptide controversies, grievances and reported side effects on one page, so people can inspect the original sources and make better-informed judgments. We seek broad coverage, but cannot guarantee that every post is captured.

Some posts and comments are searched for and collected automatically by a bot for convenience. Inclusion does not mean endorsement or confirmation. Collection counts, review status and documented verification status are displayed openly above; unverified accounts remain labelled as such.

Verification remains the reader’s responsibility

Peptide Observatory does not undertake to independently verify every post or comment and does not guarantee the accuracy, authenticity or completeness of third-party claims. We accept no responsibility for verifying those claims. A source link, review label or certificate record does not establish that a reported event occurred as described, or that a peptide caused it.

Share your experience with integrity

We welcome honest reports of grievances, suspected side effects and other peptide experiences. Describe what you personally observed, distinguish facts from suspicion, and include dates, dose, product or lot details and supporting public sources where available. Disclose relevant commercial interests. Do not fabricate, exaggerate or share another person’s identifying information.

Use “Submit a report” to contribute. Direct submissions are stored for review and are not immediately published or added to the statistics. These accounts are not medical advice or a substitute for clinical assessment.

PUBLIC POSTS & COMMENTS

Read posts and comments

Some posts and comments are found and collected automatically by a bot for convenience. Automated collection does not verify the author, product, reported experience or claim.

Loading collection…

Public anecdotal incident register

Source-read accounts. People, diagnosis and product identity remain unverified.

13 / 13 records
Research and harm reduction. Reported doses describe exposures; they are not dosing recommendations.